Phathom Pharmaceuticals, Inc. (PHAT) › Shareholders' EquityPhathom Pharmaceuticals, Inc. (PHAT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $02018: -$1.29M2019: $227.96M2020: $194.27M2021: $72.16M2022: -$74.81M2023: -$72.76M2024: -$253.58M2025: -$438.17M-$438.17M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$438.17M-72.8%2024-$253.58M-248.5%2023-$72.76M+2.7%2022-$74.81M-203.7%2021$72.16M-62.9%2020$194.27M-14.8%2019$227.96M+17825.9%2018-$1.29M—2017$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share